Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

The Genomics Core houses a 10X Genomics Chromium iX which has the capacity to prepare ... most genomic data - including bulk and single cell RNAseq, ATAC-seq, Cut&Run, ChIP-seq, and Cut&Tag. We are ...

Constantly escalating US-China tensions and sanctions on China’s semiconductor industry and import of advanced chips only compounded market participant ... In the long run, 10x Genomics targets that ...

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...